文献速递肾癌与肾肿瘤

经腹腔机器人辅助肾部分切除术最小随访5年:单中心肿瘤学与功能学结局

Transperitoneal Robot-assisted Partial Nephrectomy with Minimum Follow-up of 5 Years: Oncological and Functional Outcomes from a Single Institution.
PubMed 文献 · Eur Urol Oncol · 2018-07-14

该单中心研究纳入2006年10月起连续接受经腹腔机器人辅助肾部分切除术(RAPN)的278例肾细胞癌(RCC)患者,要求随访至少5年。结果显示5年和7年RCC死亡累积发生率均为1.80%,局部复发累积发生率为3.61%和4.16%,转移累积发生率为3.24%和4.57%;末次随访时平均eGFR较基线下降10.6ml/min(95%CI -12.56至-8.66;p<0.0001),早期术后下降后肾功能保持稳定。

要点

  • 278例RAPN患者中,5年和7年RCC死亡累积发生率均为1.80%。
  • 5年和7年局部复发累积发生率分别为3.61%和4.16%,转移为3.24%和4.57%。
  • 末次随访平均eGFR较基线下降10.6ml/min(95%CI -12.56至-8.66;p<0.0001)。

核心结论

  • 这是首项报告RAPN后最小肿瘤学随访5年的研究,结果显示在选定队列中RAPN具有优异的长期肿瘤学结局。
  • 数据证实RAPN后肾功能在术后早期下降后随时间保持稳定。

研究设计与样本

  • 单中心研究,数据来自前瞻性维护的机构性肾部分切除术数据库,纳入自2006年10月起连续接受经腹腔RAPN的RCC患者。
  • 排除良性肿瘤、基因突变、既往根治性肾切除术或同侧肾部分切除术、以及随访不足5年的患者,最终纳入278例RAPN。
  • 采用线性随机效应模型评估随访时长对eGFR的影响,并校正潜在混杂因素;采用单变量竞争风险回归分析癌症相关事件的HR。

主要发现

  • 随访期间共28例死亡(10.1%),其中5例(1.8%)与转移性RCC相关。
  • 5年和7年RCC死亡累积发生率均为1.80%,局部复发累积发生率分别为3.61%和4.16%,转移累积发生率分别为3.24%和4.57%。
  • 末次随访(中位46个月,四分位距30-58)时平均eGFR差异为-10.6ml/min(95%CI -12.56至-8.66;p<0.0001),随访各时间点eGFR均显著低于基线。
  • 单变量竞争风险回归显示,更高的Fuhrman分级(HR 8.76;p=0.051)、更大的肿瘤尺寸(HR 1.67;p<0.0001)和肿瘤坏死(HR 16.73;p=0.0019)为RCC死亡的独立预测因素。

局限性

  • 回顾性设计以及早期RAPN经验中患者选择导致的潜在选择偏倚可能限制研究结果的普遍性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Robot-assisted partial nephrectomy (RAPN) is an established, minimally invasive nephron-sparing technique with excellent perioperative and intermediate oncological outcomes. However, long-term oncological outcomes have not been reported to date. OBJECTIVE: To report oncological and functional outcomes of RAPN among patients with minimum follow-up of 5 yr. DESIGN, SETTING, AND PARTICIPANTS: Data for consecutive patients undergoing RAPN since October 2006 were extracted from a prospectively-maintained institutional PN database. Patients with benign tumors, genetic mutations, prior radical or ipsilateral PN, and those with follow-up of <5 yr were excluded. INTERVENTION: Transperitoneal RAPN for renal cell carcinoma (RCC). OUTCOMES MEASUREMENTS AND STATISTICAL ANALYSIS: Demographic, perioperative, postoperative, functional, and oncological data were evaluated. A linear random-effects model was used to estimate the effect of follow-up duration on the estimated glomerular filtration rate (eGFR) after adjustment for potential confounders. Univariable competing-risks regression analyses were performed to evaluate the hazard ratio (HR) for cancer-related events for the variables of interest. RESULTS AND LIMITATIONS: A total of 278 RAPNs for RCC were included. eGFR was significantly lower at follow-up time points than at baseline. At last follow-up (median 46 mo, interquartile range 30-58) the mean eGFR difference was -10.6ml/min (95% confidence interval -12.56 to -8.66; p < 0.0001). There were 28 deaths (10.1%) in the cohort during the follow-up period, of which five (1.8%) were related to metastatic RCC. The 5-yr and 7-yr cumulative incidence of RCC deaths was 1.80% at both 5 and 7 yr, while the cumulative incidence of local recurrence was 3.61% and 4.16%, and that of metastasis was 3.24% and 4.57% at 5 and 7 yr, respectively. Univariable competing-risks regression revealed that higher Fuhrman grade (HR 8.76; p = 0.051), larger tumor size (HR 1.67; p < 0.0001), and tumor necrosis (HR 16.73; p = 0.0019) were independent predictors of RCC death. The retrospective design and potential selection bias due to patient selection in the early RAPN experience may limit the generalizability of the findings. CONCLUSIONS: This is the first study reporting minimum oncological follow-up of 5 yr after RAPN. The results demonstrate excellent long-term oncological outcomes after RAPN in a selected cohort of patients. Our data confirm that the renal functional deterioration after RAPN remains stable over time after the early postoperative decrease. PATIENT SUMMARY: Robot-assisted partial nephrectomy is being more widely used as a standard treatment for small localized renal cell carcinomas. This study reveals excellent long-term cancer control for both local recurrences and distant metastases. Renal function is stable after an initial postoperative deterioration.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Bertolo R, Garisto J, Dagenais J, et al. Transperitoneal Robot-assisted Partial Nephrectomy with Minimum Follow-up of 5 Years: Oncological and Functional Outcomes from a Single Institution. Eur Urol Oncol. 2018. PMID: 31017098. doi:10.1016/j.euo.2018.06.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。